Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2

Mostrar otras versiones (1)

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has high transmissibility and recently swept the globe. Due to the extensive number of mutations, this variant has high level of immune evasion, which drastically reduced the efficacy of existing antibodies and vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Zhenhao, Peng, Lei, Filler, Renata, Suzuki, Kazushi, McNamara, Andrew, Lin, Qianqian, Renauer, Paul A., Yang, Luojia, Menasche, Bridget, Sanchez, Angie, Ren, Ping, Xiong, Qiancheng, Strine, Madison, Clark, Paul, Lin, Chenxiang, Ko, Albert I., Grubaugh, Nathan D., Wilen, Craig B., Chen, Sidi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863141/
https://www.ncbi.nlm.nih.gov/pubmed/35194606
http://dx.doi.org/10.1101/2022.02.14.480449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863141/
https://www.ncbi.nlm.nih.gov/pubmed/35194606
http://dx.doi.org/10.1101/2022.02.14.480449

Ejemplares similares